• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

11.63 -0.85 (-6.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,597,003
Open 12.40
Bid (Size) 11.68 (100)
Ask (Size) 11.86 (800)
Prev. Close 12.48
Today's Range 11.62 - 12.45
52wk Range 5.600 - 17.43
Shares Outstanding 38,086,437
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
CorMedix Inc (NASDAQ:CRMD): A Textbook Fit for a High-Growth Stock Screener ↗
December 29, 2025
CorMedix (CRMD) exemplifies a high-growth stock with explosive sales, strong earnings momentum, and robust profitability, fitting a proven investment framework. 
Via Chartmill
News headline image
Why CorMedix Could be the Biopharma Name to Watch Early in 2026 ↗
December 23, 2025
Via MarketBeat

Performance

YTD
+41.5%
+41.5%
1 Month
+18.8%
+18.8%
3 Month
N/A
N/A
6 Month
-1.4%
-1.4%
1 Year
+43.6%
+43.6%

More News

Read More
News headline image
MarketBeat’s Top 5 Rated Small-Cap Stocks ↗
December 22, 2025
Via MarketBeat
News headline image
Why Is CorMedix Stock Rising Today? ↗
December 18, 2025
Via Stocktwits
News headline image
CorMedix Inc (NASDAQ:CRMD) Shows Explosive Growth Metrics in "Little Book" Screen ↗
December 08, 2025
Via Chartmill
CorMedix Stock Breaks Out To 2-Month High: Analysts Reset Price Targets After Blowout Q3 And Surging DefenCath Demand ↗
November 13, 2025
Via Stocktwits
News headline image
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Via Benzinga
CRMD Stock Is The Talk Of The Town Today: What’s The Latest 2025 Revenue Forecast? ↗
October 20, 2025
Via Stocktwits
News headline image
Analyst Expectations For Cormedix's Future ↗
September 09, 2025
Via Benzinga
News headline image
Talphera (TLPH) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics Earnings
News headline image
CorMedix Q3 Profit Soars As DefenCath Dialysis Demand Exceeds Expectations ↗
November 12, 2025
Via Benzinga
News headline image
Pharming Group Posts Upbeat Q3 Results, Joins On Holding, BigBear.ai Holdings And Other Big Stocks Moving Higher On Wednesday ↗
November 12, 2025
Via Benzinga
News headline image
Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance ↗
November 12, 2025
Via Stocktwits
Topics Earnings
News headline image
CorMedix Inc. (NASDAQ:CRMD) Q3 2025 Earnings: Revenue Beat Offsets EPS Miss ↗
November 12, 2025
Via Chartmill
News headline image
CorMedix Inc (NASDAQ:CRMD) Fulfills Key Growth Stock Criteria from The Little Book ↗
November 11, 2025
Via Chartmill
News headline image
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗
November 10, 2025
Via Benzinga
News headline image
Halper Sadeh LLC Encourages CorMedix Inc. Shareholders to Contact the Firm to Discuss Their Rights
October 22, 2025
From Halper Sadeh LLC
Via Business Wire
News headline image
Beyond The Numbers: 4 Analysts Discuss Cormedix Stock ↗
October 21, 2025
Via Benzinga
News headline image
CorMedix Inc (NASDAQ:CRMD) Fits a Proven Growth Strategy with Strong Fundamentals ↗
October 21, 2025
Via Chartmill
News headline image
CorMedix Inc (NASDAQ:CRMD) Identified as a Top Growth Stock Candidate ↗
September 29, 2025
Via Chartmill
News headline image
CorMedix Inc (NASDAQ:CRMD) Embodies a Proven Growth Investing Strategy ↗
September 08, 2025
Via Chartmill
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
September 02, 2025
Via Benzinga
News headline image
CORMEDIX INC (NASDAQ:CRMD) – A High-Growth Stock Aligned with Louis Navellier’s Investment Strategy ↗
August 18, 2025
Via Chartmill
News headline image
Elliott Management Bets Against S&P 500, Nasdaq 100, Nvidia Stock In Second Quarter ↗
August 14, 2025
Via Benzinga
Topics Stocks
News headline image
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes ↗
August 08, 2025
Via Benzinga
Topics Bankruptcy

Frequently Asked Questions

Is CorMedix Inc. - Common Stock publicly traded?
Yes, CorMedix Inc. - Common Stock is publicly traded.
What exchange does CorMedix Inc. - Common Stock trade on?
CorMedix Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for CorMedix Inc. - Common Stock?
The ticker symbol for CorMedix Inc. - Common Stock is CRMD on the Nasdaq Stock Market
What is the current price of CorMedix Inc. - Common Stock?
The current price of CorMedix Inc. - Common Stock is 11.63
When was CorMedix Inc. - Common Stock last traded?
The last trade of CorMedix Inc. - Common Stock was at 12/31/25 04:00 PM ET
What is the market capitalization of CorMedix Inc. - Common Stock?
The market capitalization of CorMedix Inc. - Common Stock is 442.95M
How many shares of CorMedix Inc. - Common Stock are outstanding?
CorMedix Inc. - Common Stock has 443M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap